Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exercise-induced bronchospasm in clinical practice.

W E Pierson1

  • 1University of Washington, Seattle 98105.

Clinical Reviews in Allergy
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxidant and acid aerosol exposure in healthy subjects and subjects with asthma. Part I: Effects of oxidants, combined with sulfuric or nitric acid, on the pulmonary function of adolescents with asthma.

Research report (Health Effects Institute)·1994
Same author

Pulmonary function changes in children associated with fine particulate matter.

Environmental research·1993
Same author

Respiratory effects of inhaled sulfuric acid on senior asthmatics and nonasthmatics.

Archives of environmental health·1993
Same author

Particulate air pollution and hospital emergency room visits for asthma in Seattle.

The American review of respiratory disease·1993
Same author

Respiratory effects of air pollution on allergic disease.

The Journal of allergy and clinical immunology·1992
Same author

The effect of duration of exposure on sulfuric acid-induced pulmonary function changes in asthmatic adolescent subjects: a dose-response study.

Toxicology and industrial health·1992
Same journal

Immunosuppressive agents and asthma.

Clinical reviews in allergy·1994
Same journal

Leukotriene and thromboxane antagonists.

Clinical reviews in allergy·1994
Same journal

Novel approaches in immunotherapy.

Clinical reviews in allergy·1994
Same journal

Potassium channel openers and asthma.

Clinical reviews in allergy·1994
Same journal

The legal liability of the Institutional Review Board.

Clinical reviews in allergy·1994
Same journal

New perspectives in information retrieval.

Clinical reviews in allergy·1994
See all related articles

Early recognition and management of exercise-induced bronchospasm (EIB) enable children and adolescents to participate in sports. Diagnosis involves questionnaires and exercise challenge tests, with management including nonpharmacologic and pharmacologic strategies.

Area of Science:

  • Pediatrics
  • Sports Medicine
  • Pulmonology

Background:

  • Exercise-induced bronchospasm (EIB) can limit physical activity in children and adolescents.
  • Early diagnosis and management are crucial for enabling participation in sports and physical activities.

Purpose of the Study:

  • To review diagnostic methods for EIB.
  • To outline nonpharmacologic and pharmacologic management strategies for EIB.
  • To discuss the use of EIB medications in athletic competition.

Main Methods:

  • Diagnosis relies on patient history (coughing, chest congestion, decreased exercise performance).
  • Systematic questionnaires can identify individuals with EIB.
  • Exercise challenge tests (treadmill, cycloergometer) confirm exercise-induced bronchospasm.

Related Experiment Videos

Main Results:

  • Nonpharmacologic management includes warm-ups, rebreathing masks, and anaerobic fitness training.
  • Pharmacologic options include cromolyn sodium, beta-adrenergic agonists, theophylline, ipratroprium bromide, calcium channel blockers, and terfenadine.
  • Approved medications can be used in national and international competitions.

Conclusions:

  • Effective management of EIB allows children and adolescents to fully engage in physical activities.
  • A combination of diagnostic tools and tailored management strategies is essential.
  • Pharmacologic treatments are viable options for athletes with EIB, subject to regulatory approval.